Cell & Gene Therapy
Increasing Patient Safety: Risk assessment for small volume fluid management
Autologous therapies and other ATMPs with small volumes exhibit certain specific requirements. The scope of handling advanced therapies require special handling and care. When handling of small volumes is already automated in an early stage, it is a way more straightforward path to commercialization of the drug product. The benefit of a closed systems with automated solutions add value by offering a higher degree of sterility, safety, and process flexibility.
Brian Moloney
December 4, 2023
